Research Article
[Retracted] MicroRNA-4325 Suppresses Cell Progression in Hepatocellular Carcinoma via GATA-Binding Protein 6
Table 1
Clinicopathological characteristics of patients (
).
| Characteristic | | MicroRNA-4325 expressiona | value | High, | Low, |
| Sex | | | | | Male | 24 | 13 | 11 | 0.21 | Female | 6 | 2 | 4 |
| Age (years) | | | | | <65 | 20 | 12 | 8 | 1.35 | ≥65 | 10 | 3 | 7 |
| Tumor size (cm) | | | | | <5 | 22 | 13 | 9 | 1.53 | ≥5 | 8 | 2 | 6 |
| Grade | | | | | II | 5 | 4 | 1 | 0.96 | III | 25 | 11 | 14 |
| Node metastasis | | | | | With | 25 | 11 | 14 | 0.96 | Without | 5 | 4 | 1 |
| α-Fetoprotein (ng/ml) | | | | | <50 | 16 | 10 | 6 | 1.21 | ≥50 | 14 | 5 | 9 |
|
|
aHigh or low expression was defined based on a cut-off value of 50%.
|